RECALL RECORD — CLASS IRecall closedF-3042-2015/FDA enforcement
Natar Foods, INC.·Food·Apr 17, 2015

Dry Bream-lesh (Fish), NET WT

What you need to know

Class I
  • What happened

    The product was found to be uneviscerated based on sampling and analysis by New York State Department of Agriculture & Markets

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. A safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall closed · classified by the FDAFL, IA, MI, MD +3 moreMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameNatar Foods, INC.
Recalling firmNatar Foods, INC.Brooklyn, NY, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • Best before 11-08-2015
Distribution area
FLIAMIMDMANYVA

FL, IA, MI, MD, MA, NY & VA

United States

Quantity affected3 boxes (approximately 80 pieces)
Recall initiationFDA report date: August 26, 2015
FDA recall numberF-3042-2015

Beyond the headline

The recall, in context

Natar Foods, INC. initiated this food recall on April 17, 2015. The FDA enforcement report states: The product was found to be uneviscerated based on sampling and analysis by New York State Department of Agriculture & Markets. The FDA report lists distribution as: FL, IA, MI, MD, MA, NY & VA.

The FDA enforcement report describes the reason as: The product was found to be uneviscerated based on sampling and analysis by New York State Department of Agriculture & Markets

Dry Bream-lesh (Fish), NET WT was made or distributed by Natar Foods, INC. in Brooklyn, NY, United States. This page reflects FDA report F-3042-2015, dated August 26, 2015.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, a safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Product safety recall

Symptoms to watch for

The official enforcement report describes the specific risk. Follow the recall notice, check the product codes and do not use a product that may be affected.

Higher-risk groups

Children, pregnant people, older adults and people with weakened immune systems should take extra care when a product's safety is uncertain.

What to do now

  1. 1Stop using or eating the product and keep it away from children and pets.
  2. 2Check the UPC and lot/date codes on this page and follow the official recall notice for disposal or return.
  3. 3Seek medical advice if anyone develops severe or worrying symptoms after exposure.

Read the official source record for the specific hazard and instructions.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Dry Bream-lesh (Fish), NET WT recall?

Natar Foods, INC. recalled Dry Bream-lesh (Fish), NET WT in an FDA Class I enforcement action reported as F-3042-2015. The product was found to be uneviscerated based on sampling and analysis by New York State Department of Agriculture & Markets

What are the symptoms of Product safety recall exposure?

The official enforcement report describes the specific risk. Follow the recall notice, check the product codes and do not use a product that may be affected.

Who is most at risk from Product safety recall?

Children, pregnant people, older adults and people with weakened immune systems should take extra care when a product's safety is uncertain.

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Stop using or eating the product and keep it away from children and pets. Check the UPC and lot/date codes on this page and follow the official recall notice for disposal or return. Seek medical advice if anyone develops severe or worrying symptoms after exposure.

How do I get a refund from Natar Foods, INC.?

Contact the recalling company or the retailer where you purchased the product, quote the FDA recall number and ask about a refund or replacement. Keep the packaging, lot code and proof of purchase where possible. The FDA does not issue consumer refunds. Reference FDA recall F-3042-2015 and keep the packaging, lot code and proof of purchase if you have them.

Is the Natar Foods, INC. recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-3042-2015. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Related alerts

Recent Other safety concern recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.